The introduction in 2006 of a highly effective vaccine against human papillomavirus (HPV) exposed the need for population-based surveillance of HPV-related diseases. In 2007, the Centers for Disease Control and Prevention funded a collaboration between CEIP and the California Department of Public Health STD Control Branch to develop a comprehensive plan to conduct surveillance of cervical pre-cancer including cervical intraepithelial neoplasia (CIN) 2/3 and adenocarcinoma in situ (AIS). This surveillance effort is ongoing in Alameda County, California.
- Determine the burden of CIN 2/3 and AIS in Alameda County and monitor trends in incidence
- Conduct HPV testing for a subset of cases to monitor HPV types
- Monitor and evaluate the impact of the HPV vaccines
As of September 23, 2013, high-grade cervical pre-cancer is reportable in Alameda County. Please see additional information on reporting eligible cases.
HPV-Impact produces an annual newsletter about the surveillance effort, HPV in the news, and findings to date. Please read more below.
If you would like to be added to the HPV-Impact newsletter mailing list, enter your information below:
In the News
- January 2018: The United States Congress designated January as Cervical Health Awareness Month. Nearly 13,000 women in the United States are diagnosed with cervical cancer each year, but the disease is virtually always preventable with vaccination and appropriate screening (Pap and HPV tests).
- September 2017: Gynecologic Cancer Awareness Month
- October 2016: Updated recommendations from ACIP for use of a 2-dose HPV vaccine schedule
- December 2014: The FDA Approves Gardasil 9
How is information requested? See a sample case report form that may be faxed to providers.
National Collaborating Surveillance Sites and Participating Institutions
- Alameda County Public Health Department
- Connecticut Emerging Infections Program, Yale University
- Tennessee Department of Health, Tennessee Emerging Infections Program, Vanderbilt University
- New York Emerging Infections Program, University of Rochester
- Oregon Emerging Infections Program, State of Oregon Department of Human Services
- Kaiser Permanente of Northern California
- Ina Park, MD MS
Medical Director for the California Prevention Training Center
Associate Professor, UCSF School of Medicine
- Erin Whitney, MPH
HPV Surveillance Project Coordinator
STD Control Branch, California Department of Public Health
850 Marina Bay Parkway, Bldg P, 2nd Floor
Richmond, CA 94804
For more information on HPV and the HPV vaccine:
- The American Sexual Health Association’s Cervical Health Awareness website
- Published HPV-Impact articles on PubMed.gov
- The Centers for Disease Control and Prevention HPV Page
- The California Department of Public Health Human Papillomavirus (HPV) Page
- Advisory Committee on Immunization Practices (ACIP) Recommendations for the HPV Vaccine
- 2014 National Immunization Survey-Teen results released with newest HPV Vaccination Uptake and Safety Data
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years – United States, 2014